Outcome of transition phase patients with juvenile idiopathic arthritis

References

• Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet. 2007;369:767–78.
   PubMed Web of Science ®Google Scholar
• Berntson L, Andersson Gare B, Fasth A, Herlin T, Kristinsson J, Lahdenne P, et al. Incidence of juvenile idiopathic arthritis in the Nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteria. J Rheumatol. 2003;30:2275–82.
   PubMed Web of Science ®Google Scholar
• Hersh A, von Scheven E, Yelin E. Medscape. Adult outcomes of childhood-onset rheumatic diseases. Nat Rev Rheumatol. 2011;7:290–5.
   PubMed Web of Science ®Google Scholar
• Nordal E, Zak M, Aalto K, Berntson L, Fasth A, Herlin T, et al. Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis. Arthritis Rheum. 2011;63:2809–18.
   PubMed Web of Science ®Google Scholar
• Elhai M, Bazeli R, Freire V, Feydy A, Drape JL, Quartier P, et al. Radiological peripheral involvement in a cohort of patients with polyarticular juvenile idiopathic arthritis at adulthood. J Rheumatol. 2013;40:520–7.
   PubMed Web of Science ®Google Scholar
• Stoll ML, Cron RQ. Treatment of juvenile idiopathic arthritis: a revolution in care. Pediatr Rheumatol Online J. 2014;12:13
   PubMed Web of Science ®Google Scholar
• Rosen DS, Blum RW, Britto M, Sawyer SM, Siegel DM. Society for Adolescent Medicine. Transition to adult health care for adolescents and young adults with chronic conditions: position paper of the society for adolescent medicine. J Adolesc Health. 2003;33:309–11.
   PubMed Web of Science ®Google Scholar
• Tucker LB, Cabral DA. Transition of the adolescent patient with rheumatic disease: issues to consider. Rheum Dis Clinics North Am. 2007;33:661–72.
   PubMed Web of Science ®Google Scholar
• Hazel E, Zhang X, Duffy CM, Campillo S. High rates of unsuccessful transfer to adult care among young adults with juvenile idiopathic arthritis. Pediatr Rheumatol. 2010;8:2–6.
   PubMed Web of Science ®Google Scholar
• Stringer E, Scott R, Mosher D, MacNeill I, Huber AM, Ramsey S, et al. Evaluation of a rheumatology transition clinic. Pediatr Rheumatol Online J. 2015;13:22–9.
   PubMed Web of Science ®Google Scholar
• Foster HE, Minden K, Clemente D, Leon L, McDonagh JE, Kamphuis S, et al. EULAR/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseases. Ann Rheum Dis. 2016;76:639–46.
   PubMed Web of Science ®Google Scholar
• Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980;23:137–45.
   PubMed Web of Science ®Google Scholar
• Prevoo ML, van ’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:44–8.
   PubMed Web of Science ®Google Scholar
• Aletaha D, Smolen JS. The definition and measurement of disease modification in inflammatory rheumatic diseases. Rheum Dis Clin North Am. 2006;32:9–44.
   PubMed Web of Science ®Google Scholar
• van der Heijde DM, van ’t Hof MA, van Riel PL, Theunisse LA, Lubberts EW, van Leeuwen MA, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis. 1990; 49:916–20.
   PubMed Web of Science ®Google Scholar
• van der Heijde DM, van ’t Hof M, van Riel PL, van de Putte LB. Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol. 1993; 20:579–81.
   PubMed Web of Science ®Google Scholar
• Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol. 1994;21:2286–91.
   PubMed Web of Science ®Google Scholar
• Shammas RM, Ranganath VK, Paulus HE. Remission in rheumatoid arthritis. Curr Rheumatol Rep. 2010;12:355–62.
   PubMedGoogle Scholar
• Ammerlaan JW, Scholtus LW, Bijlsma HJ, Prakken BJ, Kruize AA. An urge for change: transitional care for young adults with juvenile idiopathic arthritis. Patient Educ Counsel. 2013;92(1):127–9.
   PubMed Web of Science ®Google Scholar
• Berntson L, Damgard M, Andersson-Gare B, Herlin T, Nielsen S, Nordal E, et al. HLA-B27 predicts a more extended disease with increasing age at onset in boys with juvenile idiopathic arthritis. J Rheumatol. 2008;35:2055–61.
   PubMed Web of Science ®Google Scholar
• Miyamae T, Tanaka E, Kishi T, Matsuyama T, Igarashi T, Fujikawa S, et al. Long-term outcome of 114 adult JIA patients in a non-pediatric rheumatology institute in Japan. Mod Rheumatol. 2015;25:62–6.
   PubMed Web of Science ®Google Scholar
• Minden K, Niewerth M, Listing J, Biedermann T, Bollow M, Schontube M, et al. Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum. 2002;46:2392–401.
   PubMed Web of Science ®Google Scholar
• Foster HE, Marshall N, Myers A, Dunkley P, Griffiths ID. Outcome in adults with juvenile idiopathic arthritis: a quality of life study. Arthritis Rheum. 2003;48:767–75.
   PubMed Web of Science ®Google Scholar
• Wallace CA, Huang B, Bandeira M, Ravelli A, Giannini EH. Patterns of clinical remission in select categories of juvenile idiopathic arthritis. Arthritis Rheum. 2005;52:3554–62.
   PubMed Web of Science ®Google Scholar
• Wallace CA, Giannini EH, Spalding SJ, Hashkes PJ, O’Neil KM, Zeft AS, et al. Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis. Arthritis Rheum. 2012;64:2012–21.
   PubMed Web of Science ®Google Scholar
• Tynjälä P, Vähäsalo P, Tarkiainen M, Kröger L, Aalto K, Malin M, et al. Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial. Ann Rheum Dis. 2011;70:1605–12.
   PubMed Web of Science ®Google Scholar
• Verazza S, Negro G, Marafon D, Consolaro A, Martini A, Ravelli A. Possible discontinuation of therapies after clinical remission in juvenile idiopathic arthritis. Clin Exp Rheumatol. 2013;31:S98–S101.
   PubMed Web of Science ®Google Scholar
• Berntson L, Nordal E, Aalto K, Peltoniemi S, Herlin T, Zak M, et al. HLA-B27 predicts a more chronic disease course in an 8-year followup cohort of patients with juvenile idiopathic arthritis. J Rheumatol. 2013;40:725–31.
   PubMedGoogle Scholar
• Taxter AJ, Wileyto EP, Behrens EM, Weiss PF. Patient-reported outcomes across categories of juvenile idiopathic arthritis. J Rheumatol. 2015;42:1914–21.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Welfare. Smoking in Finland. Available from: https://www.thl.fi/fi/web/alcohol-tobacco-and-addictions/tobacco/smoking-in-finland [last accessed Mar 2017].
   Google Scholar
• Aaltonen KJ, Sokka T, Möttönen T, Korpela M, Komulainen R, Uusitalo T, et al. A nationwide cross-sectional overview of patients with rheumatoid arthritis followed in outpatient specialty clinics in Finland. Scand J Rheumatol. 2014;43:286–90.
   PubMed Web of Science ®Google Scholar
• Vidqvist KL, Malin M, Varjolahti-Lehtinen T, Korpela MM. Disease activity of idiopathic juvenile arthritis continues through adolescence despite the use of biologic therapies. Rheumatology. 2013;52:1999–2003.
   PubMed Web of Science ®Google Scholar
• Wipff J, Sparsa L, Lohse A, Quartier P, Kahan A, Deslandre CJ. Impact of juvenile idiopathic arthritis on quality of life during transition period at the era of biotherapies. Joint Bone Spine. 2016;83:69–74.
   PubMed Web of Science ®Google Scholar
• Ngo ST, Steyn FJ, McCombe PA. Gender differences in autoimmune disease. Front Neuroendocrinol. 2014;35:347–69.
   PubMed Web of Science ®Google Scholar
• Aaltonen KJ, Joensuu JT, Pirilä L, Kauppi M, Uutela T, Varjolahti-Lehtinen T, et al. Drug survival on tumour necrosis factor inhibitors in patients with rheumatoid arthritis in Finland. Scand J Rheumatol. 2017;46:359–63.
   PubMed Web of Science ®Google Scholar